MALAT1 and metabolic dysfunction-associated steatotic liver disease: MALAT1 was consistently upregulated in 5 out of 7 HBV-HCC datasets (log2FC > 1), while no significant or consistent change was observed in HCV- or NAFLD-related HCC.